Organization · Venture Capital

FemHealth Ventures

FemHealth Ventures is a women-led venture capital firm based in New York City that invests in health-related businesses focused on advancing women's health. The firm targets companies that develop scalable healthcare solutions specifically for women.

Venture CapitalFunder

Official website Official pitch route

Overview

What FemHealth Ventures does

What FemHealth Ventures is

How it participates in the startup ecosystem

The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.

Operational profile

Organization status and context

Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.

Operational status: Active
Organization type: Venture Capital
Founded: Founded in 2020
Approximate age: About 6 years
Structured capabilities: Funder
Last reviewed: May 5, 2026

Official channels

Find FemHealth Ventures elsewhere

Open the official website or a supported primary organization account.

Capability profile

FemHealth Ventures as a funder

Official pitch route

Investment thesis

FemHealth Ventures invests in health solutions that transform women’s health while targeting strong financial returns. The firm focuses on conditions that appear only in women, mostly in women, or differently in women.

Focus narrative

FemHealth Ventures invests in companies that create healthcare solutions specifically for women. Their investment strategy categorizes women's health conditions into three categories: those that appear only in women, those that appear mostly in women, and those that manifest differently in women. The firm targets investments in drugs, medical devices, diagnostics, and digital health solutions.

Value beyond capital

FemHealth Ventures adds value to its portfolio companies by leveraging its expertise in women's health to guide product development and market strategies. The firm supports entrepreneurs in navigating the complexities of healthcare innovation, providing access to a network of industry experts and potential partners, and facilitating connections with healthcare providers and payers.

Terms and economics

Typical check: $1,000,000–$10,000,000

Focus and fit

Stages: Seed · Series A · Series B · Growth Equity
Sectors: Healthcare · Biotech · Medical Devices · Diagnostics · Digital Health · AI
Regions: United States

Availability

Currently deploying: Yes

Portfolio and track record

Recorded portfolio count: 20
Recorded notable exits: Gynesonics

Portfolio context

Notable portfolio companies include: Ossium Health: Innovative health solutions. Iantrek: Medical technologies for glaucoma. GT Medical Technologies: Advanced medical devices for brain tumors. 10Beauty: Beauty and health products. Alyssum Therapeutics: Therapeutic innovations. Evommune: Immune health solutions. Mendaera: Health technologies for needle-based procedures. Brixton Biosciences: Bioscience innovations. Imperative Care: Medical devices for vascular diseases. Cercle: Health technology interpreting real-world data. Kanvas Biosciences: Bioscience solutions. Reunion Neuroscience: Neuroscience innovations. IgGenix: Immunology solutions. Gynesonics (acquired): Women's health technologies. Sequel Med Tech: Medical technologies. inSoma Bio: Biotechnology. AOA Dx: Diagnostic innovations for ovarian cancer. Rejoni: Hydrogel to prevent intrauterine adhesions. Nymbl Science: Health technologies. Raydiant Oximetry: Medical devices for fetal distress detection. BioAesthetics: Aesthetic health solutions.

Connected ecosystem